GCS1 Antikörper (N-Term)
-
- Target Alle GCS1 (MOGS) Antikörper anzeigen
- GCS1 (MOGS) (Mannosyl-Oligosaccharide Glucosidase (MOGS))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser GCS1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Verwendungszweck
- Rabbit polyclonal antibody raised against synthetic peptide of GCS1.
- Kreuzreaktivität
- Human
- Immunogen
- A synthetic peptide (conjugated with KLH) corresponding to N-terminus of human GCS1.
-
-
- Applikationshinweise
-
ELISA (1:1000)
Western Blot (1:100-500)
The optimal working dilution should be determined by the end user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- In PBS (0.09 % sodium azide)
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
-
Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.
-
-
Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb)." in: Glycobiology, Vol. 12, Issue 8, pp. 473-83, (2002) (PubMed).
: "A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency." in: American journal of human genetics, Vol. 66, Issue 6, pp. 1744-56, (2001) (PubMed).
: "
-
Processing of N-linked carbohydrate chains in a patient with glucosidase I deficiency (CDG type IIb)." in: Glycobiology, Vol. 12, Issue 8, pp. 473-83, (2002) (PubMed).
-
- Target
- GCS1 (MOGS) (Mannosyl-Oligosaccharide Glucosidase (MOGS))
- Andere Bezeichnung
- MOGS / GCS1 (MOGS Produkte)
- Gen-ID
- 7841
- Pathways
- SARS-CoV-2 Protein Interaktom
-